Robert Winn named director of VCU Massey Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Robert Winn was named director of Virginia Commonwealth University Massey Cancer Center. The lung cancer and community-based health care expert will begin his role at VCU Dec. 2.

Winn comes to VCU from the University of Illinois at Chicago, where he has served as director of the University of Illinois Cancer Center and as associate vice chancellor of health affairs for community-based practice at the University of Illinois Hospital and Health Science System. At UIC, Winn built a community-to-bench integrated health model that brings together both the discovery and implementation sciences into one health delivery and research system, and he oversaw the research and clinical activities of 13 Federally Qualified Health Centers.

Prior to joining UIC, Winn spent 13 years at the University of Colorado Health Sciences Center and School of Medicine in leadership roles and clinical faculty appointments, including associate dean of admissions, vice chair of career development/diversity inclusion and senior medical director of the pulmonary nodule clinic.

“I am incredibly impressed with the cancer center’s research, clinical and educational programs as well as the collaboration that Massey fosters across VCU, VCU Health and beyond to discover, develop, deliver and teach effective means to prevent, detect, treat and cure cancer,” Winn said in a statement. “Also, Massey’s commitment to ensuring equal access to cancer care is deeply important to me.”

Winn is a pulmonologist whose scholarship has focused on lung cancer, health disparities and community-based health care. His basic science research, which was supported by NIH and Veterans Affairs Merit awards, focuses on the mechanisms that drive the proliferation of cancer and on the role of cellular senescence in lung cancer. He is a principal investigator on several community-based projects funded by the NIH and NCI, including the All of Us Research Program, a NIH precision medicine initiative. His research aims to develop methods to eliminate health disparities.

Winn replaces Gordon Ginder, who has served as Massey’s director for 22 years and announced his desire to step down last summer.

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login